Laxman Yetukuri

1PUBLICATIONS
7CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|Jul 20, 2018
PP2A inhibition is a druggable MEK inhibitor resistance mechanism in KRAS-mutant lung cancer cells.

Otto Kauko, Caitlin M O'Connor, Evgeny Kulesskiy

Pageof 1

Frequent Collaborators

1 joint publications

Otto Kauko

1 joint publications

Bhagwan Yadav

1 joint publications

Artur Padzik

1 joint publications

Teemu Daniel Laajala

1 joint publications

Majid Momeny

1 joint publications

Taru Varila

1 joint publications

Tero Aittokallio

Frequent Collaborators

1 joint publications

Otto Kauko

1 joint publications

Bhagwan Yadav

1 joint publications

Artur Padzik

1 joint publications

Teemu Daniel Laajala

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing
05:17

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing

Published on : Oct 10, 2025

419
See more related videos

Top Related Videos

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing
05:17

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing

Published on : Oct 10, 2025

419
See more related videos